Effect of Branched-Chain Amino Acid Infusion on In-Hospital Mortality of Patients With Hepatic Encephalopathy and End-Stage Kidney Disease: A Retrospective Cohort Study Using a National Inpatient Database

Leise, 2014, Management of hepatic encephalopathy in the hospital, Mayo Clin Proc, 89, 241, 10.1016/j.mayocp.2013.11.009 Van de Poll, 2004, Renal metabolism of amino acids: its role in interorgan amino acid exchange, Am J Clin Nutr, 79, 185, 10.1093/ajcn/79.2.185 Holecek, 2015, Ammonia and amino acid profiles in liver cirrhosis: effects of variables leading to hepatic encephalopathy, Nutrition, 31, 14, 10.1016/j.nut.2014.03.016 Okada, 2017, D-serine, a novel uremic toxin, induces senescence in human renal tubular cells via GCN2 activation, Sci Rep, 7, 11168, 10.1038/s41598-017-11049-8 Kalaitzakis, 2007, Renal function and cognitive impairment in patients with liver cirrhosis, Scand J Gastroenterol, 42, 1238, 10.1080/00365520701373983 Gines, 2009, Renal failure in cirrhosis, N Engl J Med, 361, 1279, 10.1056/NEJMra0809139 Cerra, 1985, Disease-specific amino acid infusion (F080) in hepatic encephalopathy: a prospective, randomized, double-blind, controlled trial, J Parenter Enteral Nutr, 9, 288, 10.1177/0148607185009003288 Rossi Fanelli, 1986, Use of branched chain amino acids for treating hepatic encephalopathy: clinical experiences, Gut, 27, 111, 10.1136/gut.27.Suppl_1.111 Vilstrup, 1990, Branched chain enriched amino acid versus glucose treatment of hepatic encephalopathy. A double-blind study of 65 patients with cirrhosis, J Hepatol, 10, 291, 10.1016/0168-8278(90)90135-E Fukui, 2016, Evidence-based clinical practice guidelines for liver cirrhosis 2015, J Gastroenterol, 51, 629, 10.1007/s00535-016-1216-y Vilstrup, 2014, Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver, Hepatology, 60, 715, 10.1002/hep.27210 Okada, 2020, Outcomes of lactulose plus branched-chain amino acid infusion and lactulose alone for hepatic encephalopathy: a retrospective cohort study using a national inpatient database, Hepatol Res, 50, 693, 10.1111/hepr.13486 Cano, 2006, Application of branched-chain amino acids in human pathological states: renal failure, J Nutr, 136, 299S, 10.1093/jn/136.1.299S Holecek, 2018, Branched-chain amino acids in health and disease: metabolism, alterations in blood plasma, and as supplements, Nutr Metab (Lond), 15, 33, 10.1186/s12986-018-0271-1 Pupim, 2002, Intradialytic parenteral nutrition improves protein and energy homeostasis in chronic hemodialysis patients, J Clin Investig, 110, 483, 10.1172/JCI0215449 Goodkin, 2003, Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the dialysis outcomes and practice patterns study (DOPPS), J Am Soc Nephrol, 14, 3270, 10.1097/01.ASN.0000100127.54107.57 Collaborators, 2020, The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017, Lancet Gastroenterol Hepatol, 5, 245, 10.1016/S2468-1253(19)30349-8 Yamana, 2017, Validity of diagnoses, procedures, and laboratory data in Japanese administrative data, J Epidemiol, 27, 476, 10.1016/j.je.2016.09.009 Ono, 2007, Indications for computed tomography in patients with mild head injury, Neurologia medico-chirurgica, 47, 291, 10.2176/nmc.47.291 Wada, 2018, Development and validation of an ICD-10-based disability predictive index for patients admitted to hospitals with trauma, Injury, 49, 556, 10.1016/j.injury.2017.12.021 Quan, 2011, Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries, Am J Epidemiol, 173, 676, 10.1093/aje/kwq433 Austin, 2009, Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples, Stat Med, 28, 3083, 10.1002/sim.3697 Zhou, 2020, Propensity score weighting under limited overlap and model misspecification, Stat Methods Med Res, 29, 3721, 10.1177/0962280220940334 Leyrat, 2019, Propensity score analysis with partially observed covariates: how should multiple imputation be used?, Stat Methods Med Res, 28, 3, 10.1177/0962280217713032 Gluud, 2017, Branched-chain amino acids for people with hepatic encephalopathy, Cochrane Database Syst Rev, 5, CD001939 1984 Egberts, 1985, Branched chain amino acids in the treatment of latent portosystemic encephalopathy. A double-blind placebo-controlled crossover study, Gastroenterology, 88, 887, 10.1016/S0016-5085(85)80004-4 Bailey, 2010, Nutritional considerations in kidney disease: core curriculum 2010, Am J Kidney Dis, 55, 1146, 10.1053/j.ajkd.2010.02.345 Tapper, 2015, Refining the ammonia hypothesis: a physiology-driven approach to the treatment of hepatic encephalopathy, Mayo Clin Proc, 90, 646, 10.1016/j.mayocp.2015.03.003 Tajiri, 2018, Branched-chain amino acids in liver diseases, Transl Gastroenterol Hepatol, 3, 47, 10.21037/tgh.2018.07.06 Ikeda, 2017, Slc3a2 mediates branched-chain amino-acid-dependent maintenance of regulatory T cells, Cell Rep, 21, 1824, 10.1016/j.celrep.2017.10.082 Deleaval, 2020, Short-term effects of branched-chain amino acids-enriched dialysis fluid on branched-chain amino acids plasma level and mass balance: a randomized cross-over study, J Ren Nutr, 30, 61, 10.1053/j.jrn.2019.03.079 Plauth, 1990, Characteristic pattern of free amino acids in plasma and skeletal muscle in stable hepatic cirrhosis, Hepatogastroenterology, 37, 135 Campollo, 1992, The BCAA/AAA ratio of plasma amino acids in three different groups of cirrhotics, Rev Invest Clin, 44, 513 Kawaguchi, 2011, Branched-chain amino acids as pharmacological nutrients in chronic liver disease, Hepatology, 54, 1063, 10.1002/hep.24412 Małgorzewicz, 2008, Serum concentration of amino acids versus nutritional status in hemodialysis patients, J Ren Nutr, 18, 239, 10.1053/j.jrn.2007.11.011 Kimer, 2014, Systematic review with meta-analysis: the effects of rifaximin in hepatic encephalopathy, Aliment Pharmacol Ther, 40, 123, 10.1111/apt.12803 Kaji, 2017, Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity, World J Gastroenterol, 23, 8355, 10.3748/wjg.v23.i47.8355 Mueller, 2011, A.S.P.E.N. clinical guidelines: nutrition screening, assessment, and intervention in adults, J Parenter Enteral Nutr, 35, 16, 10.1177/0148607110389335